Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21718006 | 0.91 | ESR1 (0.44) | KMT2ALMNASMN1; SMN2KDM4EL3MBTL1 | |
| SCHEMBL21710641 | 0.88 | KDM4E (0.39) | KMT2ALMNASMN1; SMN2KDM4EATM | |
| SCHEMBL20227464 | 0.87 | KMT2A (0.43) | KMT2ALMNASMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL21710577 | 0.86 | KDM4E (0.40) | KMT2AKDM4EATML3MBTL1HSD17B10 | |
| SCHEMBL21717362 | 0.85 | PTGES (0.34) | KMT2ALMNASMN1; SMN2KDM4EESR1 | |
| SCHEMBL21717850 | 0.85 | TSPO (0.39) | KMT2ALMNAKDM4EATML3MBTL1 | |
| SCHEMBL21710687 | 0.85 | KDM4E (0.39) | KMT2AKDM4EATML3MBTL1HSD17B10 | |
| SCHEMBL19563943 | 0.84 | ESR1 (0.47) | KMT2ALMNASMN1; SMN2KDM4EL3MBTL1 | |
| SCHEMBL10153493 | 0.84 | GPR3 (0.42) | KMT2AKDM4EATML3MBTL1HSD17B10 | |
| SCHEMBL21454044 | 0.83 | TSPO (0.38) | KMT2ALMNAKDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029119-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-11723272-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20210005825-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2021-01-07 | — | — | US | disclosed |
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029119-B2 | Organic electroluminescence element and electronic device | LEF1, L1CAM, ESR2 | KMT2A 2275/4885LMNA 853/4885SMN1; SMN2 3776/4885 |
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | LEF1, L1CAM, ESR2 | KMT2A 2275/4885LMNA 853/4885SMN1; SMN2 3776/4885 |
| US-20210005825-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | OR51E2, CD99, CTNND1 | KMT2A 2064/4885LMNA 1900/4885SMN1; SMN2 3628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.